Inflammatory Bowel Disease

More in Inflammatory Bowel Disease

Atopic Dermatitis Linked to Increased IBD Risk in Adults and Kids

Risk increased with severity of atopic dermatitis across both groups, cohort study shows

Aug 30, 2023
A photo of the arm of a child with atopic dermatitis.
U.S. Unveils First 10 Drugs for Medicare Price Negotiations

Treatments for heart failure, Crohn's disease, and diabetes make the list

Aug 29, 2023
A photo of two bottles of Eliquis tablets.
Doctors, Patients Try to Shame Insurers to Reverse Prior Auth Denials

Many have taken to social media to get tests, drugs, and treatments approved

Aug 27, 2023
 A photo of a Blue Cross Blue Shield corporate building in Chicago, Illinois
First Multiple Sclerosis Biosimilar Approved

Natalizumab-sztn gets a nod from the FDA

Aug 25, 2023
FDA APPROVED natalizumab-sztn (Tyruko) over a computer rendering of a damaged neuron.
Microbiome Study Provides New Clues to Common Pathology of Inflammatory Conditions

Microbiota similarities, differences in patients with spondyloarthritis, Crohn's disease, uveitis

Aug 08, 2023
A computer rendering of microvilli with microbiota.
Psychological Therapy May Have Some Benefits for IBD Patients

Meta-analysis shows benefits for mood, quality of life, but not disease activity

Aug 07, 2023
A computer rendering of the intestinal tract superimposed over the brain of a transparent head.
TNF Blockers for IBD Tied to Risk for Immune-Mediated Diseases

"Paradoxical" finding puzzles researchers

Jul 22, 2023
A computer rendering of a transparent body with inflamed intestines highlighted.
Mirikizumab Benefit in UC Extends Into Maintenance Phase

Twice as many responders achieved clinical remission at week 40 versus placebo

Jun 28, 2023
A computer rendering of monoclonal antibodies.
Inflammatory Bowel Disease Linked With Increased Stroke Risk

Swedish study is largest, with longest follow-up to date

Jun 14, 2023
A computer rendering of a transparent man with his brain and intestines highlighted.
A Close Look at the Data Backing Upadacitinib's Approval in Crohn's

Compared with placebo, the JAK inhibitor improved clinical remission and endoscopic response

May 25, 2023
A photo of a bottle of Rinvoq over a computer rendering of inflamed intestines
First JAK Inhibitor Approved for Crohn's Disease

Upadacitinib lands indication for moderately to severely active disease in adults

May 18, 2023
FDA APPROVED upadacitinib (Rinvoq) over a computer rendering of inflamed intestines in a transparent body.
Win for Vedolizumab in Recurrent Crohn's Disease

Trial boosts case for label expansion

May 08, 2023
DDW over a photo of McCormick Place in Chicago, Illinois.
Better Cardiorespiratory Endurance Tied to Lower IBD Risk in Kids, Teens

Other measures of physical fitness not independently associated with IBD risk

May 01, 2023
A photo of children running an obstacle course during class.
Vedolizumab Proves Its Worth in Treating Chronic Pouchitis

Biologic effective for common complication of ileal pouch-anal anastomosis in ulcerative colitis

Mar 29, 2023
A vial of Entyvio over a computer rendering of ulcerative colitis.
More in Inflammatory Bowel Disease

Continuing Medical Education